BioSpace News Archive

SeraLabs Challenges the Status Quo of the Health & Wellness Sector with Nutri-Strips for commercialization and monetization with the launch of first product, Sleep A.S.A.P.

INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that it will host a conference call on Thursday, November 5, 2020 at 4:30 PM Eastern Time to discuss results for its third quarter ended September 30, 2020 and to provide a

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the third quarter ended September 30, 2020, after the market close on Thursday, November 5, and will host a corporate update conference call at 4:30pm EST. Thursday ,

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced a strategic collaboration with Insightec Ltd., a global healthcare company focused on the therapeutic power of acoustic energy. Under the agreement, Lantheus’ micr

Immutep Limited (ASX: IMM; NASDAQ: IMMP), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce that it has entered into a Licence and Collaboration Agreement with LabCorp that will support the development of immuno-oncology products or services. “Over the years, Immutep has generated a significant amount of know-how in immuno-oncology, specifically in terms of LAG-3,”

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company will host a conference call and live webcast on Thursday, November 12, 2020 at 5:00 p.m. ET to report third quarter 2020 financial results and discuss recent business highlights. To access the live conference call, please

Ziopharm Oncology, Inc., announced the Company will host a conference call and webcast on Thursday, November 5, at 4:30 pm EDT to provide a corporate update and discuss financial results for the third quarter ended September 30, 2020.

FDA-approved prescription drugs Lysodren® and Metopirone® in the United States

AbCellera and Kodiak Sciences Inc., announced a new partnership to generate therapeutic antibody candidates in ophthalmology.

Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced the commercial launch of XARACOLL® implant for acute postsurgical pain relief up to 24 hours in adults following open inguinal hernia repair, a painful and commonly performed surgery.1